LIFE SCIENCE  | 
PHYSICAL SCIENCE  | 
RESEARCH TOOLS  | 
SOFTWARE AND COPYRIGHT
TECHNOLOGY COMMERCIALIZATION HOME  | 
SEARCH
Search Results - disease
5
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
A Gene Knockout Mouse Model to Study Lung
Disease
and a Lung Disease Drug Target
Our researchers have created a gene knockout mouse model that lacks the cytochrome c oxidase subunit IV-2 in order to study the gene’s effects on controlling asthma. Background & Unmeet Need: Asthma is an inflammatory
disease
of the airways that affects 155 million people of all ages worldwide. Cytochome c oxidase (CcO) is a multi-subunit...
Published: 3/3/2022
|
Inventor(s):
Maik Huettemann
,
Lawrence Grossman
,
David Bassett
Keywords(s):
Asthma
,
Disease
,
Drug Target
,
Gene
,
Knock-out
,
Lung
,
Mouse Model
Category(s):
Animal models
,
Biological materials
,
Life Science
,
Research tools
,
Protein/peptides
Inhibitors of the ubiquitin E3 ligase BCA2 as anti-cancer therapeutic agents
Background:Breast cancer associated protein 2 (BCA2) is a ubiquitin E3 ligase found in invasive breast cancer. Studies have shown that by decreasing its activity, breast cancer cell growth and invasiveness are diminished. Targeting this ligase and inhibiting its activity could play a role in treatment of breast cancer. A molecular approach to inhibiting...
Published: 3/12/2018
|
Inventor(s):
Angelika Burger
,
Andrew Westwell
Keywords(s):
Analog or Analogue
,
Breast Cancer
,
Cancer
,
Disease
,
Drug Target
,
Enzyme
Category(s):
Disease
s
,
Oncology
,
Therapeutics
,
Life Science
,
Research tools
Modified Ectodomain of Human EGFR as a Potential Anticancer Agent
Development of a protein that attenuates EGFR and/or EGFR family members and is comprised of a modified EGFR ectodomain. The protein inhibits signaling via the EGFR and/or EGFR family members. The protein includes a portion of the EGFR (or EGFR family member) and the "U" region epitope of EGFR related protein (ERRP), wherein the portion of...
Published: 8/16/2021
|
Inventor(s):
Adhip Majumdar
,
Arun Rishi
,
Yingjie Yu
Keywords(s):
Breast Cancer
,
Cancer
,
Cancer Therapies
,
Disease
,
Drug Target
,
Protein
,
Therapeutics
Category(s):
Life Science
,
Biologicals
,
Disease
s
,
Oncology
Antibacterial activity of natural compounds and their synthetic analogue: A potential new antibiotic with potent activity against multiple drug resistant bacterial pathogens
Our researchers have developed novel compounds that are potential new anti-infective therapeutics useful for treatment against the deadly bacteria MRSA (methicillin-resistant Staphylococcus aureus), VRE (vancomycin-resistant Enterococcus faecium), and several other well-known common infectious agents.Background & Unmet Need:Before antibiotics became...
Published: 8/9/2022
|
Inventor(s):
Hossein Salimnia
,
Fazlul Sarkar
,
Subhash Padhye
,
Bernhard Biersack
Keywords(s):
Analog or Analogue
,
Antibiotics
,
Anti-infective
,
Anti-microbial
,
Disease
Category(s):
Biologicals
,
Disease
s
,
Infectious
disease
,
Life Science
,
Therapeutics
DNA Molecule Encoding the B3 Adrenegic Receptor
This technology describes the correct protein sequence of the β3 receptor to aid in the development of adult-onset diabetes drugs. Background & Unmet Need: The β3 receptor is currently being developed as a therapeutic target for human obesity and adult onset diabetes mellitus by several pharmaceutical companies. In order to develop...
Published: 3/2/2022
|
Inventor(s):
James Granneman
,
Kristine Lahners
,
Donald Rao
Keywords(s):
Diabetes
,
Disease
,
DNA
,
Drug Target
,
Obesity
,
Therapeutics
Category(s):
Life Science
,
Metabolic disorders
,
Diagnostics
,
Research tools
,
Receptors/targets